Perrigo Company plc Fair Value Inputs, Discount Rate (Deprecated 2018-01-31)
Perrigo Company plc (PRGO) reported Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) of 7.75% for the 9-month period ending 2016-10-01, per its 10-Q/A filed 2017-05-23.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueInputsDiscountRate · last filed 2018-03-01
- Perrigo Company plc fair value inputs, discount rate (deprecated 2018-01-31) for the quarter ending 2016-04-02 was 7.62%.
- Perrigo Company plc fair value inputs, discount rate (deprecated 2018-01-31) for fiscal 2015 was 7.72%.
- Perrigo Company plc fair value inputs, discount rate (deprecated 2018-01-31) for fiscal 2015 was 7.83%.
| Period end | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) 3 month | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) 6 month | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) 9 month | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-10-01 | 7.75% 10-Q/A · filed 2017-05-23 | |||
| 2016-07-02 | 7.52% 10-Q/A · filed 2017-05-22 | |||
| 2016-04-02 | 7.62% 10-Q/A · filed 2017-05-22 | |||
| 2015-12-31 | 7.72% 10-Q/A · filed 2017-05-22 | 7.72% 10-K · filed 2018-03-01 | ||
| 2015-06-27 | 7.83% 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |